Differential diagnosis of solitary pulmonary nodules using 99mTc-3P4-RGD2 scintigraphy

• Published in: European journal of nuclear medicine and molecular imaging 2011-12, Vol.38 (12), p.2145-2152
• Main Authors: Ma, Qingjie, Ji, Bin, Jia, Bing, Gao, Shi, Ji, Tiefeng, Wang, Xueju, Han, Zhenguo, Zhao, Guoqing
• Format: Article
• Language: English
• Subjects: Adult; Aged; Cardiology; Diagnosis, Differential; Female; Humans; Imaging; Lung Neoplasms - diagnostic imaging; Male; Medicine; Medicine & Public Health; Middle Aged; Nuclear Medicine; Oligopeptides; Oncology; Organotechnetium Compounds; Original Article; Orthopedics; Radiology; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Solitary Pulmonary Nodule - diagnostic imaging; Tomography, Emission-Computed, Single-Photon - methods
• ISSN: 1619-7070; 1619-7089
• DOI: 10.1007/s00259-011-1901-2

Purpose Targeting of integrin α ν β 3 with molecular imaging agents offers great potential in early detection and monitoring of tumour angiogenesis. Recently, an RGD (Arg-Gly-Asp) tracer, 99m Tc-3P 4 -RGD 2 , with high affinity to integrin α ν β 3 and in vivo tumour uptake was developed. In this study, we evaluate the feasibility of this novel radiotracer in the noninvasive differentiation of solitary pulmonary nodules (SPNs). Methods Twenty-one patients with SPNs on CT were studied scintigraphically after administration of 99m Tc-3P 4 -RGD 2 with a dose of 939 ± 118 MBq. Image interpretation using a 5-point scale was performed by one thoracic radiologist for CT and three nuclear medicine radiologists for single photon emission computed tomography (SPECT). Scintigraphic images were also analysed semiquantitatively by calculating tumour to normal tissue ratio (T/N). The “gold standard” was based on the histopathological diagnosis of the surgical samples from all recruited patients. A fraction of the samples were analysed immunohistochemically for integrin α v β 3 expression. Results Among the 21 SPNs, 15 (71%) were diagnosed as malignant and 6 (29%) were benign. The mean size for SPNs was 2.2 ± 0.6 cm. The sensitivity and specificity for CT interpretation, SPECT visual and semiquantitative analysis were 80/67%, 100/67% and 100/67%, respectively. All SPNs classified as indeterminate by CT were correctly diagnosed by 99m Tc-3P 4 -RGD 2 scintigraphy. The empirical receiver-operating characteristic (ROC) areas were 0.811 [95% confidence interval (CI) 58–95%] for CT, 0.833 (95% CI 61–96%) for SPECT and 0.844 (95% CI 62–96%) for T/N ratios, respectively. Immunohistochemistry confirmed α ν β 3 expression in malignant and benign nodules with uptake in 99m Tc-3P 4 -RGD 2 scintigraphy. Conclusion In this first-in-human study, we demonstrated the feasibility of using 99m Tc-3P 4 -RGD 2 scintigraphy in differentiating SPNs. This procedure appears to be highly sensitive in detection of malignant SPNs. SPECT visual analysis seems to be sufficient for characterization of SPNs.